+91-9836913164  (India), +1-414-240-5010 (U.S.)
Nicotinamide Adenine Dinucleotide Market to Reach $1812 Millionby 2032
Published : November 2022

According to a market report, published by Sheer Analytics and Insights, The global nicotinamide adenine dinucleotide market was valued at $400.1 Million in 2021 and it is expected to reach $1812 Million at a CAGR of 14.4% between 2022 and 2032. The demand for NAD among pharmaceutical producers is being fueled by the popularity of NAD as an active component in the manufacturing process of numerous health medications. Nicotinamide adenine dinucleotide is available in food grade, pharmaceutical grade, and other grades. NAD is one of the other items in the category. It is used in lab chemicals for research and diagnostic purposes. As a research and laboratory enzyme, NAD acts as a crucial cofactor for different redox processes, and these are driving its use in a variety of diagnostic tests, including those that detect ethanol and lactate dehydrogenase. Additionally, governments now have to control the use of NAD for dietary or medicinal purposes as a result of this. However, promising studies studying the advantages of NADH and NAD molecules may someday assist business players in overcoming this restriction.

Over the next eight years, there will likely be a continued strong demand for dietary supplements containing nicotinamide adenine dinucleotide. Demand for nutritional supplements has increased as a result of the growing popularity of functional products and supplementation. This is promoting the uptake of NAD supplements, which are known to boost NAD circulation in the bloodstream. It is hypothesized that this will drive product acceptance in dietary supplements. NAD is utilized to construct and repair the molecules that make up our bodies as well as to catalyze chemical reactions that are necessary to produce energy. These acts have an impact on consumer demand and favorably impact growth. Additionally, the product's performance will be further optimized by technological innovation and progress, opening up a larger range of downstream market applications. Hence, these primary factors are expected to accelerate market growth during the forecast period from 2022 to 2032.

Request a Sample Copy of Report: https://www.sheeranalyticsandinsights.com/request-sample/nicotinamide-adenine-dinucleotide-market-21

The number of people looking for treatments for age-related illnesses is rising as the average lifetime of humans continues to rise throughout the world. A crucial enzyme for several vital cell processes, including metabolism, DNA repair, cell development, and survival, is nicotinamide mononucleotide. Furthermore, several metabolic interventions that extend lifespan in mice, such as exercise, calorie restriction, and regular sleep schedules, function in part by raising NAD+ levels. This lends more credence to the notion that promoting NAD metabolism may contribute to extending human health span and, potentially, lifespan.

On the other side, according to certain research, consuming too much NAD can have some negative consequences, such as nausea, rashes, headaches, dizziness, bloating, and skin problems like itching and sweating. Therefore, these negative consequences could hinder the expansion of the market. These factors are estimated to hamper the market growth over the forecast period from 2022 to 2032.

Some new developments in the global nicotinamide Adenine Dinucleotide market:

On 18th July, 2022, through the website ActiveLifestyleNutrition.com for nutritional supplements, JZZ Technologies, Inc. started selling NAD products. The goal of NAD supplements is to actively raise the level of NAD in the bloodstream. Healthy ageing may be supported and some age-related health changes slowed by maintaining healthy levels of this coenzyme.

According to the study, key players dominating the global nicotinamide Adenine Dinucleotide market are Catalent Inc (U.S), Juvilant Pharmova (India), Himedia Laboratories Pvt Ltd (India), Krackeler Scientific (U.S), Lasons India Pvt Ltd (India), Novo Nordisk (Denmark), NutriScience Innovations (U.S), OYC Americas (U.S), Otto Chemie Pvt Ltd (India), TCI Chemicals (Japan), among others.

The Global Nicotinamide Adenine Dinucleotide Market Has Been Segmented Into:

The Global Nicotinamide Adenine Dinucleotide Market – by Grade Type:

  • Pharmaceutical Grade
  • Food Grade
  • Others

The Global Nicotinamide Adenine Dinucleotide Market – by Application Type:

  • Dietary Supplement
  • Pharmaceutical Industry
  • Others

The Global Nicotinamide Adenine Dinucleotide Market – by Regions:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East
    • Saudi Arabia
    • UAE
    • Others
  • Latin America
    • Brazil
    • Chile
    • Others
  • Africa
    • South Africa
    • Egypt
    • Others

Browse the full report at https://www.sheeranalyticsandinsights.com/market-report-research/nicotinamide-adenine-dinucleotide-market-21

About Us

Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, and electronics, materials, consumer goods, defense, and BFSI sector.

Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting. 


Sheer Analytics and Insights

Email: sales@sheeranalyticsandinsights.com

Call Us:- +1-414-240-5010

Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links